Metformin Linked to Dementia, Parkinson's in Patients With T2DM

Long-term use of the diabetes medication metformin may increase the risk for neurodegenerative disease in patients with type 2 diabetes mellitus (T2DM), new research suggests. In a cohort study that followed about 9300 patients with T2DM in Taiwan for up to 12 years, the risk for Parkinson's disease (PD) or Alzheimer's dementia was more than double during a 12-year period for those who took metformin vs those who did not — even after adjusting for multiple confounders. In addition, outcome risks increased progressively with higher dosage and longer duration of treatment.

Read more

Cow's Milk Interferes with Absorption of Thyroid Supplement Levothyroxine

Post Gardasil Heart Failure, Ragged Red Fibers and Thiamine